Journal News
-
Friday, February 03, 2012 | Source: European Heart Journal
-
By Caitlin E. Cox
Systemic inflammation occurs in a substantial proportion of patients after transcatheter aortic valve replacement (TAVR), according to a paper published…
-
Friday, February 03, 2012 | Source: Society of Thoracic Surgeons
-
By L.A. McKeown
Among ‘real world’ patients with multivessel disease, percutaneous coronary intervention (PCI) improves survival compared with coronary artery bypass…
-
Thursday, February 02, 2012 | Source: Society of Thoracic Surgeons
-
By Jason Kahn
While cohort A of the PARTNER trial established transcatheter aortic valve replacement (TAVR) as noninferior to surgical AVR for high risk patients…
-
Thursday, February 02, 2012 | Source: Journal of the American College of Cardiology
-
By Yael L. Maxwell
On the heels of the United States Food and Drug Administration’s (FDA) November 2011 approval of the first prosthetic device for use in transcatheter…
-
Wednesday, February 01, 2012 | Source: Journal of the American College of Cardiology
-
By Kim Dalton
Drawing on 2 years’ worth of new data, an expert task force has published updated appropriate use criteria for revascularization. The new guidelines,…
-
Wednesday, February 01, 2012 | Source: New England Journal of Medicine
-
By Caitlin E. Cox
Carotid endarterectomy (CEA) and carotid artery stenting (CAS) produce equivalent levels of restenosis out to 2 years following intervention, according…
-
Tuesday, January 31, 2012 | Source: Archives of Internal Medicine
-
By Yael L. Maxwell
Iodinated contrast media exposure is associated with development of hyperthyroidism as well as overt hypothyroidism, according to results from a study…
-
Tuesday, January 31, 2012 | Source: Circulation
-
By L.A. McKeown
The presence of severe symptomatic aortic stenosis has little impact on rates of short term mortality and procedural complications in patients undergoing…
-
Monday, January 30, 2012 | Source: Conference on Cell Therapy for Cardiovascular Disease
-
By Kim Dalton
NEW YORK, NY—Data from a pair of small, preliminary studies suggest that stem cell therapy is safe and may improve long term cardiac function in patients…
-
Monday, January 30, 2012 | Source: Journal of the American College of Cardiology
-
By Jason Kahn
Despite different baseline and anatomical characteristics, women with severe aortic stenosis show equivalent short term benefits from transcatheter…
ACC News
-
Monday, September 26, 2011 | Source: Clinical Trials
-
By Clinical Trials
The goal of the trial was to evaluate pretreatment with
clopidogrel 600 mg compared with 300 mg among patients with
ST-segment elevation myocardial…
-
Friday, September 09, 2011 | Source: Journal Scans
-
By Journal Scans
Coronary thrombus was seen in 15% of the patients.
Preprocedural thienopyridines and glycoprotein (GP) IIb/IIIa
inhibitors were associated with a…
-
Tuesday, August 30, 2011 | Source: Clinical Trials
-
By Clinical Trials
Darexaban is a novel oral factor Xa inhibitor, and has been
shown to be effective in the treatment of venous thromboembolism
(VTE). The current…
-
Tuesday, August 30, 2011 | Source: Clinical Trials
-
By Clinical Trials
Numerous studies have documented the safety and efficacy of
drug-eluting stent (DES) use over bare-metal stent (BMS) use in
patients presenting…
-
Tuesday, August 30, 2011 | Source: Clinical Trials
-
By Clinical Trials
Patients presenting with anterior ST-segment elevation
myocardial infarction (STEMI) are at high risk for adverse
outcomes, despite undergoing primary…
-
Thursday, July 28, 2011 | Source: Cardiosource
-
By Journal Scans
Over a mean follow-up of 6.9 years, aspirin was associated with a reduction in MCEs (risk ratio [RR], 0.90; 95% confidence interval [CI], 0.85-0.96;…
-
Wednesday, July 27, 2011 | Source: Cardiosource
-
By Journal Scans
The mean international normalized ratio during the procedure was 2.8 in the prosthetic valve group. The mean procedure time (199 vs. 167 minutes) and…
-
Thursday, July 21, 2011 | Source: Cardiosource
-
By ACC Journal Scans
There was no difference at baseline for the following: median age 66 years, body mass index, or history of hypertension. Nonwhites were more often…
-
Thursday, July 21, 2011 | Source: Cardiosource
-
By ACC Journal Scans
The median age at repair was 6.8 months (range 1.2 months to 6.8 years). Coronary artery abnormalities were noted in seven (7%) patients. Compared…
-
Wednesday, July 20, 2011 | Source: Cardiosource
-
By ACC Journal Scans
A total of 296 participants had a cardiovascular event. The risk factors of the Framingham risk score predicted these events, with a c-statistic of…
Conference News
-
Friday, December 02, 2011 | Source: TCT 2011
-
By L.A. McKeown
SAN FRANCISCO, CA—A new type of intracoronary resistance measurement that takes advantage of a naturally occurring period of stasis in the arteries…
-
Thursday, December 01, 2011 | Source: TCT 2011
-
By Yael L. Maxwell
SAN FRANCISCO, CA—Rotational atherectomy does not increase efficacy of drug eluting stents (DES) in complex calcified lesions compared with standard…
-
Thursday, December 01, 2011 | Source: TCT 2011
-
By Jason Kahn
SAN FRANCISCO, CA—Using cryoplasty for postdilation following stent implantation reduces restenosis compared with conventional balloon angioplasty…
-
Tuesday, November 29, 2011 | Source: TCT 2011
-
By L.A. McKeown
SAN FRANCISO, CA—New generation zotarolimus eluting stents are noninferior to everolimus eluting stents at 1 year in patients with stable angina or…
-
Monday, November 28, 2011 | Source: TCT 2011
-
By Kim Dalton
SAN FRANCISCO, CA—For revascularization of restenotic lesions in drug eluting stents (DES), angioplasty with a paclitaxel coated balloon reduces late…
-
Wednesday, November 23, 2011 | Source: TCT 2011
-
By TCT Daily Staff
SAN FRANCISCO, CA—In East Asian patients on antiplatelet therapy following percutaneous coronary intervention (PCI), levels of platelet reactivity…
-
Wednesday, November 23, 2011 | Source: TCT 2011
-
By TCT Dailies Staff
SAN FRANCISCO, CA—The best strategy for treating DES in stent restenosis is implantation of a different type of DES, according to results of the prospective,…
-
Tuesday, November 22, 2011 | Source: TCT 2011
-
By TCT Daily Staff
SAN FRANCISCO, CA Patients who develop stent thrombosis after percutaneous coronary intervention are more likely to have uncovered and or malapposed…
-
Tuesday, November 22, 2011 | Source: TCT 2011
-
By TCT Daily Staff
SAN FRANCISCO, CA—Patients who have undergone percutaneous coronary intervention (PCI) may experience a decreased antiplatelet effect of clopidogrel…
-
Monday, November 21, 2011 | Source: TCT 2011
-
By Yael Maxwell
SAN FRANCISO, CA—In 6 month results, a new paclitaxel eluting bioabsorbable stent shows a strong safety profile and improved efficacy compared with an…
|